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Recessive Mutations in POLR3B,
Encoding the Second Largest Subunit of Pol III,
Cause a Rare Hypomyelinating Leukodystrophy
Martine Te´treault,1,2,9 Karine Choquet,1,3,9 Simona Orcesi,4 Davide Tonduti,4 Umberto Balottin,4
Martin Teichmann,5 Se´bastien Fribourg,5 Raphael Schiffmann,6 Bernard Brais,1 Adeline Vanderver,7
and Genevie`ve Bernard8,*
Mutations in POLR3A encoding the largest subunit of RNA polymerase III (Pol III) were found to be responsible for the majority of cases
presenting with three clinically overlapping hypomyelinating leukodystrophy phenotypes. We uncovered in three cases without
POLR3A mutation recessive mutations in POLR3B, which codes for the second largest subunit of Pol III. Mutations in genes coding
for Pol III subunits are a major cause of childhood-onset hypomyelinating leukodystrophies with prominent cerebellar dysfunction, oli-
godontia, and hypogonadotropic hypogonadism.Leukodystrophies are a heterogeneous group of neurode-
generative disorders characterized by abnormal central
nervous system white matter.1 It is estimated that at least
30% to 40% of patients with leukodystrophies remain
without a precise diagnosis despite extensive investiga-
tions.2 We recently demonstrated that the majority of
cases affected by tremor-ataxia with central hypomyelina-
tion (TACH),3,4 hypomyelination, hypodontia, and
hypogonadotropic hypogonadism (4H syndrome [MIM
612440]),5–9 and leukodystrophy with oligodontia (LO
[MIM 607694])10,11 are caused by mutations in POLR3A
(MIM 610210).12 POLR3A is the largest of the 17 subunits
that constitute RNA polymerase III (Pol III). It forms,
together with the second largest subunit (POLR3B), the
catalytic center of the enzyme. Pol III transcribes small
untranslated RNAs (e.g., tRNAs, 5S RNA, 7SK RNA, and
U6 RNA) involved in the regulation of essential cellular
processes, including transcription, RNA processing, and
translation.13 We suggested that these allelic conditions
be referred to as Pol III-related hypomyelinating leukodys-
trophies. Having not identified POLR3A mutations in four
of nine 4H syndrome cases,12 we searched for mutations
in POLR3B, which codes for the other subunit that forms
Pol III’s catalytic site.
The research project was approved by the institutional
ethics committee of the Centre de Recherche du CHUM
(CRCHUM), Montreal, Canada; the institutional review
board of the National Institute of Neurological Disorders
and Stroke, National Institutes of Health, Bethesda, Mary-
land, USA; and the Children’s National Medical Center,
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652 The American Journal of Human Genetics 89, 652–655, Novembfrom all participants. We sequenced all exons, exon-intron
boundaries and 30 and 50 UTR of POLR3B (NM_018082,
hg19) on available genomic DNA from two of the four
4H cases not found previously to carry POLR3A mutations
(individuals 1 and 2)12 and one other case of 4H syndrome
(individual 3) (Table S1, available online).
All three cases were found to be compound heterozygote
for mutations in POLR3B (Figure 1A). One missense muta-
tion in exon 15, c.1568T>A (p.Val523Glu), is common to
all three individuals, who are from different ethnic back-
grounds; two of the individuals reside in the USA and
are of mixed European descent (individuals 1 and 2), and
one individual is Italian (individual 3). This common
mutation could result from an ancestral haplotype shared
by all three individuals. However, we do not have access
to genotyping data on these individuals to validate this
hypothesis. Individual 1 carries another missense muta-
tion, also in exon 15, that changes a threonine for a lysine
at position 503 (c.1508C>A [p.Thr503Lys]). The impact of
these two missense mutations on POLR3B was assessed
with AlignGVGD, PhD-SNP, PolyPhen and SIFT. All bio-
informatics programs predicted the mutations to be path-
ogenic. In addition to the common mutation, individual
2 was carrying a deletion of one base pair (c.1533delT
[p.Ile511MetfsX513]) in exon 15 causing a frameshift
and leading to a premature stop codon at position 513.
The second mutation in individual 3 is a nonsense variant
in exon 23 (c.2686A>T) creating a stop codon at position
896 (p.Lys896X). As seen in POLR3A mutations, none of
the participants is homozygous for null mutations.12 All
parents were unaffected and found to carry one of theirUniversity, Montreal, Quebec H3A 2B4, Canada; 2Department of Molecular
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Figure 1. POLR3B Mutations
(A) Genomic sequence chromatograms and
amino acid conservation across species is shown
for all missense and nonsense POLR3B muta-
tions. Individual 1 is compound heterozygote
for mutations c.1508C>A and c.1568T>A;
individual 2 is compound heterozygote for muta-
tions c.1533delT and c.1568T>A, and individual
3 is compound heterozygote for mutations
c.1568T>A and c.2686A>T. The amino acid
conservation across species is shown for all
mutations. The following abbreviations are
used: D. melanogaster, Drosophila melanogaster;
D. rerio, Danio rerio; H. sapiens, Homo sapiens;
M. musculus, Mus musculus; S. cerevisiae, Saccharo-
myces cerevisiae.
(B) 3D representations of POLR3B missense,
deletion (frameshift), and nonsense mutations.
Point mutations identified in POLR3B are dis-
played according to their equivalent positions
in the yeast RNA Polymerase II RPB2 subunit.24
Numbers in brackets refer to the positions in
yeast RPB2. Images have been generated with
PyMol software (Schro¨dinger). RPB1 is shown in
blue, RPB2 in green, RPB7 in brown, RPB4 in
pink, RPB8 in orange, and RPB11 in magenta.affected child’s mutations. All variants appear to be
conserved across species (Figure 1A) and were absent in
more than 340 control chromosomes except for the
common mutation, c.1568T>A, which was found in
2/374 (0.5%) of control chromosomes. All control individ-
uals were of European descent. This variant has never been
reported in the SNPs database (dbSNP132).
The locations of the different mutations are shown in
Figure 1B. POLR3B (RPC2) and POLR2B (RPB2) subunits
of RNA polymerase III and RNA polymerase II, respectively,
are highly conserved proteins with a similar structure.14
Based on the extrapolation of POLR3B (RPC2) from the
yeast Pol II structure, the common mutation c.1568T>A
(p.Val523Glu) corresponds to Leu566 in POLR2B (RPB2)
that is, across species, always an aliphatic or aromatic
residue. The mutation c.1508C>A (p.Thr503lys) corre-
sponds to Ser546 in RPB2, which is highly conserved across
species. The null mutation c.2686A>T (p.Lys896X), which
corresponds to Lys979 in POLR2B (RPB2), and the deletion
mutation leading to a frameshift and to a premature stop
codon, c.1533delT (p.Ile511MetX513), which corresponds
to Ile554 in POLR2B (RPB2), are predicted to generate, if
the mRNA is stable enough, a truncated POLR3B subunitThe American Journal of Humanleading to a nonfunctional polymerase
because the active site is expected to be
largely affected in its function. Based on
the Pol III electron microscopy structure
and photocross-linking experiments,15,16
the p.Val523Glu and p.Thr503Lys residues
are located near the ‘‘jaw,’’ an area of Pol III
where POLR3D (RPC4) and POLR3E
(RPC5) are localized (counterpart of yeast
RPC53 and RPC37). These two point muta-tions are predicted to affect the POLR3B structure locally
and thus impair the proper function of RPC4 and RPC5 in
transcription.
All three cases had characteristic clinical phenotypes of
4H syndrome.5,8,17 They all presented in early childhood
with developmental delays and developed dysarthria as
well as progressive motor difficulties, including cerebellar
ataxia and, in individuals 1 and 2, progressive spasticity.
Individuals 1 and 3 both developed hypogonadotropic
hypogonadism, whereas individual 2 was too young to
evaluate for endocrine dysfunction. All three individuals
had teeth abnormalities, which are presented in Figure 2
for individuals 1 and 2 and consisted of neonatal upper
incisors, delayed eruption of deciduous teeth and perma-
nent teeth, abnormal sequence of eruption, and malposi-
tion in individual 3. The clinical features of individual
3 have been published previously.18 MRI features of the
three individuals were also characteristic of previous
descriptions of 4H syndrome19 (Figure 3).
Pol III-related hypomyelinating leukodystrophies are
a genetically and clinically heterogeneous group of disor-
ders. We demonstrated previously that POLR3A mutations
account for the majority of our relatively small group ofGenetics 89, 652–655, November 11, 2011 653
Figure 2. Teeth Abnormalities
(A and B) The teeth abnormalities seen in individual 1: unspecified
age at tooth eruption and the absence of permanent mandibular
second premolars with abnormal shape of the permanent maxil-
lary central and lateral incisors.
(C and D) The teeth abnormalities of individual 2: delayed tooth
eruption with complete retention of the primary maxillary central
incisors and the mandibular lateral incisors.
Figure 3. MRI Characteristics
(A, D, and G) Sagittal T1-weighted images of the brain for individ-
uals 1 (A), 2 (D), and 3 (G) at the level of the midline demon-
strating the thin corpus callosum and vermian cerebellar atrophy
(thick white arrows).
(B, E, and H) Axial T2-weighted images of the brain for individuals
1 (B), 2 (E), and 3 (H) at the level of the pons and the dentate
nucleus demonstrating a mild T2 hyperintensity of the cerebellar
white matter associated with the typical hypointensity of the den-
tate nucleus (small white arrows).19
(C, F, and I) Axial T2-weighted images of the brain for individuals 1
(C), 2 (F), and 3 (I) at the level of the basal ganglia showing the
mild hyperintense white matter characteristic of hypomyelina-
tion; there is relative sparing of the optic radiations and anterolat-
eral nucleus of the thalamus (small black arrows), which appear
hypointense.19affected individuals and are reporting that POLR3B muta-
tions account for the remaining cases for which DNA was
available (2/4), as well as one other case of 4H syndrome
(individual 3). It is, however, likely that genes encoding
for the other Pol III subunits are mutated in cases of hypo-
myelinating leukodystrophies. As previously suggested,
because Pol III is responsible for the transcription of transfer
RNAs (tRNAs) and other essential small RNAs, it is possible
thatmutations in POLR3A and POLR3B lead to an abnormal
Pol III function thatmight affect the levels of certain tRNAs
important for the development of the central nervous
systemwhitematter,20 leading to abnormalproteinproduc-
tion. This pathophysiological mechanism is also attributed
to leukoencephalopathy with brainstem and spinal cord
involvement and lactate elevation (LBSL [MIM 611105])
caused by mutations in the nuclear-coded mitochondrial
aspartyl-tRNA synthetase (DARS2 [MIM 610956]) and hy-
pomyelinating leukodystrophy-3 (MIM 260600) caused
by a mutation in aminoacyl-tRNA synthetase complex-
interacting-multifunctional protein 1 (AIMP1/p43 [MIM
603605]).21–23 We believe that genes coding for other Pol
III subunits and possibly genes coding for proteins interact-
ing with Pol III could bemutated in cases of genetically un-
characterized hypomyelinating leukodystrophies.Supplemental Data
Supplemental data include one table and can be found with this
article online at http://www.cell.com/AJHG/.Acknowledgments
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